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ABSTRACT: Fumonisins are a group of polyketide-derived mycotoxins produced byFusariumVerticillioides,
a filamentous fungus infecting corn and contaminating food and feeds. Fumonisins contain two tricarballylic
esters that are critical for toxicity. Here, we present genetic and biochemical data for the esterification
mechanism.FUM14 in F. Verticillioideshas been deleted by homologous recombination, and the resultant
mutant lost the ability to produce fumonisins. Two new metabolites, HFB3 and HFB4, which are biosynthetic
precursors of fumonisins lacking the tricarballylic esters, were detected in the mutant. The results suggest
thatFUM14 is required for the esterification of fumonisins.FUM14was predicted to encode a nonribosomal
peptide synthetase (NRPS) containing two domains, peptidyl carrier protein and condensation domain.
Both the intact Fum14p and the condensation domain have been expressed inE cherichia coliand purified
for activity assays. Fum14p was able to convert HFB3 and HFB4 to the tricarballylic esters-containing
fumonisins, FB3 and FB4, respectively, when incubated with tricarballylic thioester ofN-acetylcysteamine.
In addition, the condensation domain was able to convert HFB1 to FB1. These data provide direct evidence
for the role of Fum14p in the esterification of fumonisins. More interestingly, the results are the first
example of an NRPS condensation domain catalyzing a C-O bond (ester) formation, instead of the typical
C-N bond (amide) formation in nonribosomal peptides. The understanding of the esterification mechanism
provides useful knowledge for mycotoxin reduction and elimination. The study also provides new insight
into the reactions catalyzed by NRPS.
Fumonisins are polyketide-derived mycotoxins produced
by several filamentous fungi, includingFusariumVerticil-
lioides, which is a widespread pathogen of corn (1, 2). These
mycotoxins are structurally similar to the long-chain base
of sphingolipids and thus can disrupt the sphingolipid
pathway by inhibiting sphinganineN-acyltransferase (cera-
mide synthase) (3). This disruption is thought to be respon-
sible for several fatal animal diseases, such as leukoenceph-
alomalacia in horses and pulmonary edema in pigs, and the
epidemiological association of fumonisins and esophageal
cancer and neural tube defects in humans (1, 4, 5). The
fungus is associated with disease at all stages of maize plant
development, infecting the roots, stalk, and kernels. Wild-
type strains of the fungus predominantly produce the B-series
fumonisins, including fumonisin B1 (FB1),1 fumonisin B2
(FB2), fumonisin B3 (FB3), and fumonisin B4 (FB4) (Figure
1).
The chemical structure of fumonisins is characterized by
having two tricarballylic esters on the carbon backbone
(Figure 1) (2, 6). The esterification is an essential step in
the maturation of fumonisins, because without the esters the
mycotoxins are not fully active (7-9). The esters are formed
between a tricarboxylic acid (propane-1,2,3-tricarboxylic
acid) and the hydroxyls at C-14 and C-15 of the fumonisin
backbone (Figure 1). Previous studies using13C-enriched
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FIGURE 1: Chemical structure of the B-series fumonisins.
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substrates suggested that the precursor for the tricarballylic
esters may be an intermediate from the Krebs Cycle (10).
However, the biosynthetic mechanism for the ester formation
is not clear.
Proctor et al. identified a 15-gene cluster (FUM) respon-
sible for the biosynthesis of fumonisins inF. Verticillioides
(11). On the basis of the sequence annotation and preliminary
results from gene deletion experiments, Butchko et al. have
proposed that three genes,FUM7, FUM10, andFUM14, are
involved in the formation of the esters (12). The deduced
amino acid sequence ofFUM10 is similar to acyl-CoA
synthetase and the adenylation domain of nonribosomal
peptide synthetase (NRPS); the deduced amino acid sequence
of FUM14 is similar to the peptidyl carrier protein (PCP)
and condensation domain (C) of NRPS (13), and the deduced
amino acid sequence ofFUM7 is similar to dehydrogenases,
which could be regarded as a reductase domain of NRPS
(14, 15). Thus,FUM7, FUM10, andFUM14 may encode
enzymes that make up an NRPS complex.
In NRPS, the adenylation domain activates an amino acid
and transfers it to PCP as a covalently linked thioester via a
4′-phosphopantetheinyl cofactor (13, 16). The C domain then
catalyzes the condensation reaction between the acyl thioesters
on PCP to form an amide (C-N) bond. Therefore, among
the four genes,FUM14 is the most likely candidate that is
directly involved in the transfer of the acyl groups to the
hydroxyls on polyketide backbone. TheFUM14 protein
(Fum14p) could catalyze formation of the ester C-O bonds
in the biosynthesis of fumonisins. A C-O bond formation
catalyzed by an NRPS condensation domain has not been
reported in the biosynthesis of nonribosomal peptides.
Therefore, the characterization ofFUM14 not only helps
reveal the biosynthetic mechanism for the side-chain forma-
tion of fumonisins but also could shed new light on the
reactions catalyzed by NRPS. Here, we report the gene
disruption and heterologous expression ofFUM14 and in
vitro activity assays for the purified Fum14p.
EXPERIMENTAL PROCEDURES
General DNA Manipulations. Plasmids preparation and
DNA extraction were carried out by using commercial kits
(Qiagen, Valencia, CA), and all other manipulations were
carried out according to standard methods (17). Escherichia
coli DH5R strain was used as the host for general DNA
propagations, and the pGEM-zf vector series from Promega
(Madison, WI) was used for cloning and DNA sequencing.
Genomic DNA ofF. Verticillioideswas prepared as described
previously (18).
Construction of FUM14 Deletion Vector pUCH2-F14.To
construct theFUM14 vector, two DNA fragments were
amplified by PCR from Cos4-5 (11), which contains most
of the FUM gene cluster includingFUM13, FUM14, and
FUM15 (see Figure 2). A 991-bp fragment (left-side arm),
which covers the noncoding region downstream toFUM14
and the 3′-region ofFUM13, was amplified by using primers
PLF/PLR (Table 1). A 1087-bp fragment (right-side arm),
which covers the 5′-region of FUM14 and the noncoding
region upstream toFUM14, was amplified by using primers
PRF/PRR (Table 1). The right-side arm was digested with
HindIII and BamHI and cloned into plasmid pUCH2-8,
which carries a hygromycin B resistance gene (HygB) (19).
The left-side arm was digested withApaI/SalI to generate
an 834-bp fragment, which was subsequently cloned into the
ApaI/SalI site of the above construct. This generated a 7.3-
kb plasmid, pUCH2-F14, in which theHygBgene is flanked
by the left-side arm and right-side arm as shown in Figure
2. The plasmid was used to createFUM14-deleted mutants
by homologous recombination at the left-side and right-side
arms.
Transformation of F.Verticillioides and Screening for
Mutants. The procedure forF. Verticillioides protoplast
isolation and transformation was essentially identical to that
described previously (20). Briefly, the plasmid DNA (5µg)
was diluted with STC buffer (100µL final) and mixed with
protoplasts (100µL), and transformation was mediated with
PEG 8000 buffer (30% PEG 8000, 10 mM Tris-HCl, pH
8.0, and 50 mM CaCl2). Hygromycin-resistant colonies were
selected on YPD plates containing hygromycin B (150µg/
mL, Calbiochem, La Jolla, CA). Three different pairs of
primers were used in PCR to identify theFUM14-deleted
mutants from the hygromycin resistant colonies. First, a pair
of primers binding toHygB was used to verify that the
colonies contained this gene. Then, two pairs of primers (P1/
P2 and P3/P4, see Table 1 for sequences) were used to verify
that colonies positive forHygB resulted from homologous
recombination at the flanking regions ofFUM14, but not
from a random integration of the plasmid. Primer P1 binds
to a region that is outside of the left-side arm, whereas primer
P2 binds to theHygB gene (Figure 2). Therefore, only the
colonies resulting from homologous recombination at the left-
side arm could yield a PCR product of the expected size,
whereas colonies containing a randomly integrated vector
or resulting from rearrangement after the homologous
recombination would not yield this specific product. Simi-
larly, primers P3/P4 were used to confirm the homologous
recombination at the right-side arm (Figure 2). Thus,
FUM14-deleted mutants were identified from colonies that
yielded the PCR product expected for homologous recom-
bination on both the left-side and right-side arms.
Production and Extraction of Metabolites from Mutants.
The mutant strains were transferred separately to a YPD/
hygromycin (300µg/mL) plate to generate single colonies.
A single colony was then transferred to a 10 mL tube
containing 3 mL of YPD/hygromycin (150µg/mL) liquid
medium and allowed to grow in a shaker (60 rpm) at room
temperature for 2 days. From the 3 mL culture, 100µL was
transferred to a flask containing 25 mL of YPD/hygromycin
(150 µg/mL). The culture was incubated with shaking at
room temperature for another 2 days. The culture was
transferred to a 50 mL tube and centrifuged at 2500 rpm for
20 min. The pellet was washed three times with sterile water
and finally resuspended in 10 mL of sterile water. From the
suspended solution, 500µL was transferred to a new flask
containing 10 g of autoclaved CMK (Cracked Maize Kernels)
medium (11). Alternatively, colonies derived from single
spores of the mutants were inoculated on V8 agar plates.
After 1-week growth at room temperature, spores were
collected from the plates and used to inoculate the 10 g CMK
medium. After 3 weeks of incubation at room temperature
in the dark, metabolites were extracted from the CMK
cultures with 20 mL of 50% acetonitrile. The extracts were
filtered, and a sample of 50µL was injected in HPLC-ELSD
to analyze the metabolites.
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Construction of Expression Vectors.To construct the
expression vector that contained the C domain alone (Fum14-
C), a 1.3 kb fragment ofFUM14 carrying the domain was
amplified by PCR from the genomic DNA ofF. Verticillio-
ides with primers F14-C-F and F14-C-R (Table 1). High-
fidelity DNA polymerasePfu (Stratagene) was used in the
reactions. The PCR fragment was digested withBamHI and
HindIII and cloned into pGEM-3zf. After sequence fidelity
of the amplification product was confirmed by DNA
sequencing, it was transferred to expression vector pMAL-
c2 (New England BioLabs), which is designed to yield the
expressed protein fused to the maltose-binding protein
(MBP).
To construct the complete Fum14p expression vector, a
1.6 kb fragment was amplified by PCR from a cDNA library
of F. Verticillioides using the forward primer F14-F and a
reverse primer F14-R (Table 1). The PCR fragment was
digested withBamHI andXhoI and cloned into pT7Blue-3.
After confirmation by DNA sequencing, the gene was
transferred to expression vector pMAL-c2 as described
above.
Expression and Purification of Fum14-C and Fum14-PCP-
C. E. coli TB1 (New England BioLabs) strain was used for
expression from the pMAL-based constructs. The standard
conditions for cell growth and expression induction were
followed as recommended by the manufacturer. The cells
were incubated in a shaker (250 rpm) at 25°C until the cell
density reached 0.6 at OD600nm. To induce the expression of
FUM14, IPTG (0.1 mM) was added to the culture, and the
cells were allowed to grow at the same conditions for another
3 h. The soluble fraction of the overproduced proteins was
loaded to an amylose resin column (BioLabs) for affinity
purification of the proteins. The purified proteins were
desalted on a PD-10 column (Pharmacia Biotech, Piscataway,
NJ), eluted in 50 mM Tris-HCl buffer, pH 8.0, containing
FIGURE 2: The construction ofFUM14 gene deletion vector and screening of theFUM14-deleted mutants. (A) Homologous recombination
betweenFUM14 on theF. Verticillioides chromosome and the homologous sequences on plasmid pUCH2-F14. The positions for PCR
primer binding sites are indicated by small arrows. Abbreviations: A,ApaI; B, BamHI; H, HindIII; K, KpnI; Sc, SacI; Sl, SalI; HygB,
hygromycin B resistant gene. (B) Gene-replacement mutants resulted from double crossovers at the upstream homologous region (left-side
arm) and at the downstream homologous region (right-side arm). The expected size for PCR products is indicated below the corresponding
genes.
Table 1: Primers Used in the Experiments
name sequences
PLF 5′-CCG CTC GAG TAT TAC AAG GGC GAC TC-3′
PLR 5′-CGC GTC GAC GAT AGC TAG AGC ATA TTC GG-3′
PRF 5′ CGT GAA GCT TGG GAA CTC GTC CTT TCT-3′
PRR 5′CGC GGA TCC GAA GCA CAG AGT CGG AAA ACG-3′
P1 5′-GTA CAA GCA CGG ACT TGA AAG AG-3′
P2 5′-GAT GTG TTA GAA GCT CAC AGA AGG-3′
P3 5′-CAT AAC CAA GCC TAT GCC TAC AG-3′
P4 5′-GCA TAC TGC CTG TTC TAG GAT TG-3′
F14-C-F 5′-CGC GGA TCC TTG CCT TTA TGG TCT ATG-3′
F14-C-R 5′-CCC AAG CTT CTA GTC CAA CAA GCC TGT-3′
F14-F 5′-CGC GGA TCC AAT TCA TTG GAC CAG TGG-3′
F14-R 5′-CCG CTC GAG CTA GTC CAA CAA GCC TGT-3′
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200 mM NaCl, 10 mM MgCl2, 2 mM dithiothreitol (DTT),
1 mM EDTA, and 10% glycerol, and stored at-80 °C for
in vitro assays.
Preparation of HFB1, HFB3, and HFB4. The preparation
of the hydrolyzed FB1 (HFB1) and hydrolyzed FB3 (HFB3)
was conducted by using the alkaline method (21). Ap-
proximately 2 mg of fumonisins was refluxed in 2.5 mL of
0.25 N potassium hydroxide for 24 h. The solution was
acidified to pH 5 with 2 N HCl and analyzed by HPLC-
ELSD. The hydrolyzed fumonisin was purified by HPLC
and dried under vacuum. Alternatively, HFB3 and HFB4 were
prepared from the culture ofFUM14-deleted mutants. The
purified HFB was dissolved in water for enzyme activity
assays.
Synthesis of Tricarballylic Acid Monothioesters. N-Ace-
tylcysteamine (1) and phenyl (2) monothioesters of tricar-
ballylic acid were prepared as illustrated in Figure 3
(experimental details are available in Supporting Informa-
tion). Protection of cyclopentene acetic acid as the corre-
sponding trichloroethyl ester was followed by oxidative
cleavage of the alkene with ruthenium tetroxide. Thioesteri-
fication of the resulting diacid withN-acetylcysteamine and
thiophenol cleanly produced the corresponding phenyl and
SNAC monothioesters. Reductive deprotection of the trichlo-
roethyl esters furnished the tricarballylic monothioesters. As
the phenyl thioester decomposed rapidly following dissolu-
tion in neutral buffers, the biosynthetic studies were con-
ducted with theN-acetylcysteamine thioester, which was
indefinitely stable.
ActiVity Assays for Fum14p.A typical assay solution (100
µL) contained 2 mM tricarballylic thioester, 0.1 mM HFB
(HFB1, HFB3, or HFB4), 2.3µM Fum14p, and 5 mM MgCl2,
in 100 mM Tris-HCl buffer, pH 7.4. Reactions without
Fum14p were used as controls. After 30 min incubation at
37 °C, the reactions were stopped by the addition of 0.2 mL
of cold 100% ethanol. After 30 min on ice, the precipitated
protein was removed by centrifugation at 13 200 rpm at 4
°C for 20 min, and the supernatant was transferred to a new
tube and dried under vacuum. Finally, the residues in the
tube were redissolved in 50µL of water for HPLC-ELSD
and LC-ESIMS analysis.
HPLC-ELSD and ESIMS Analysis.The HPLC system
was a ProStar, model 210 from Varian (Walnut Creek, CA)
with an Alltima C18LL column (250 mm× 4.6 mm i.d.,
5µm, Alltech, Deerfield, IL). The mobile phases were (A)
water-TFA (100:0.025, v/v) and (B) acetonitrile-TFA (100:
0.025, v/v) with a gradient of 0-40% B in A in the first 10
min, 40-80% B in A from 10 to 15 min, 80% B in A from
15 to 20 min, 80-100% B in A from 20 to 21 min, 100%
B in A from 21 to 23 min, and 100-0% B in A from 23 to
25 min. The flow rate was 1.0 mL/min, and a 50µL sample
was injected. The conditions set for light-scattering detection
using an ELSD2000 (Alltech, Deerfield, IL) were the same
as described previously (22). For preparative HPLC, the
respective fractions were collected directly from the column
according to their retention times. ESIMS was carried out
on an API Qtrap 4000. The samples were directly infused
in the mass spectrometer and analyzed in positive ion mode
using Turbo Ion Spray Source.
RESULTS
FUM14-Deleted Mutants Produced HFB3 and HFB4. The
transformation ofF. Verticillioidesprotoplasts with pUCH2-
F14 resulted in 33 colonies that were able to grow on YPD
plates containing hygromycin B. The resistance phenotype
of these transformants was confirmed by the growth of the
individual colonies in liquid YPD medium containing a high
concentration (300µg/mL) of hygromycin B. The genomic
DNA isolated from the 33 transformants was then used in
PCR screening forFUM14-deleted mutants. When primers
P1/P2 were used, PCR of 12 transformants yielded a 1.4 kb
fragments, which is expected to result from a homologous
recombination of the left-side arm sequence in pUCH2-F14
and the F. Verticillioides genome (Figure 2B). The 12
colonies were further screened by PCR using primers P3/
P4. Except for one transformant, all transformants clearly
yielded a 1.3 kb fragment, which is expected to result from
a homologous recombination at the right-side arm sequence
in pUCH2-F14 and theF. Verticillioidesgenome (Figure 2B).
To further verify the identity of the transformants, the PCR
products from four representative transformants (number 23,
27, 31, and 33) were digested withKpnI and EcoRI. Two
fragments, 693 and 796 bp, were produced when the PCR
product amplified by primer P1/P2 was digested withKpnI,
whereas three fragments, 754, 446, and 141 bp, were
generated when the PCR product amplified by primers P3/
P4 was digested withEcoRI (data not shown). The presence
of HygB in each of the transformants was further verified
by PCR amplification of the gene from the genomic DNA
of the transformants, with the wild-type strain as a negative
control (data not shown). Together, the results showed that
we have obtained at least four fungal strains that areFUM14-
deleted mutants, in which the coding region ofFUM14 was
replaced withHygB(Figure 2B). The four mutants were used
in the subsequent experiments for the production and analysis
of metabolites.
After 3 weeks of growth in CMK medium, the wild-type
progenitor strain produced B-series fumonisins, FB1, FB2,
FB3, and FB4, with retention times of 16.2, 17.0, 17.2, and
18.1 min, respectively, on HPLC-ELSD (Figure 4A). The
extracts fromFUM14-deleted mutants gave three main peaks
on HPLC-ELSD, with retention times of 16.1, 16.9, and
18.1 (Figure 4B). Since the retention times are very close to
those from the wild-type strain, the extract from the wild-
type strain was combined with the extract from the mutant
and re-injected to HPLC. Two groups of peaks, with each
approximately corresponding to that of the wild-type strain
or of the mutant, were produced on HPLC-ELSD (data not
FIGURE 3: Synthesis of TCA thioesters. (a) CCl3 H2OH, DCC,
pyridine; (b) RuCl3, NaIO4; (c) N-acetylcysteamine, DCC, pyridine;
(d) thiophenol, DCC, pyridine; (e) Zn/HOAc.
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shown). The results suggest that the peaks in the extract from
mutants correspond to compounds that differ from fumonisins
produced by the wild-type progenitor strain. In the similar
spiking experiments, Peak-1 of the mutant extract did not
comigrate with standard HFB1. However, Peak-2 and Peak-3
comigrated with standard HFB3 and HFB4 (data not shown).
The three peaks were collected individually and analyzed
by ESIMS. Peak-1 exhibited a yellowish color and gave
several molecular ions, among which were [M+ H]+ of
321.3m/z for methylfusarubin and 303.3 and 337.4m/z for
the dehydrolyzed form and hydroxylated form of methyl-
fusarubin, respectively (23). These pigments have been
observed in otherFUM-deleted mutants and are not related
to fumonisins (Yu, F. and Du, L., unpublished observations).
Peak-2 gave only one clear molecular ion of 390.6m/z, which
is identical to standard HFB3. Peak-3 contained a predomi-
nant molecular ion of 374.6m/z, which is the same as
standard HFB4. The results from HPLC and ESIMS show
that FUM14-deleted mutants produce two hydrolyzed fu-
monisins, HFB3 and HFB4, but not fumonisins HFB1 or
HFB2.
Production of Fum14p-C and Fum14p in E. coli. FUM14
was initially predicted to encode only for a condensation
domain of NRPS (11). Results from the recent EST sequenc-
ing project ofF. Verticillioides showed that the start codon
of FUM14 is located upstream of the previously predicted
start codon (24). We found that the amino acid sequence
deduced from this new coding region is similar to two
domains within NRPS, a PCP domain at the N-terminus and
a condensation domain at the C-terminus. The highly
conserved 4′-phosphopantetheinyl binding motif, FFDLG-
GDSVKA (consensus sequence GGxS; serine residue being
the 4′-phosphopantetheinyl binding site), is found in the PCP
domain of Fum14p, whereas the conserved motifs, including
the C3 motif DHTHCDAFSR (typical consensus sequence
HHxxxDG), are found in the C domain of Fum14p (Figure
5) (13, 16).
We constructed expression vectors for Fum14p C domain
alone (Fum14p-C) as well as for the entire protein (Fum14p).
The corresponding regions ofFUM14 were initially cloned
into expression vector pET28a under control of a T7/lac
promoter. The proteins were overproduced inE. coli strain
BL21(DE3) upon IPTG induction. However, the produced
proteins were totally insoluble under all conditions tested.
The Fum14p- and Fum14p-C-coding regions were then
moved to the yeast expression system, pYES/NT, in the
INVSc1 strain (Invitrogen). However, the expression level
of both proteins was so extremely low that neither was
purified from this system. Finally, we moved the Fum14p-
and Fum14p-C-coding regions to the TB2/pMALc2 system
to test whether the proteins could be expressed as soluble
proteins when fused to MBP. Although the expression level
was lower than in the BL21(DE3)/pET28a, the produced
proteins appeared partially soluble. The proteins were
purified on an amylose affinity column. The single domain
protein, produced from the Fum14p-C coding region, yielded
a band at approximately the 90 kDa region on SDS-PAGE
(Figure 5A), which is consistent with the expected size for
the fusion protein (92.5 kDa). The entire Fum14p protein,
produced from the intact Fum14p coding region, yielded a
band at approximately the 100 kDa region on SDS-PAGE
(Figure 5B), which is in agreement with the expected size
for the fusion protein (104.8 kDa).
Esterification of HFB3 and HFB4 by Fum14p. Fum14p was
initially tested for the ability to transfer commercially
available acyl-CoA, including acetyl-CoA, malonyl-CoA,
and succinyl-CoA, to hydrolyzed fumonisins. However,
none of the acyl-CoA appeared to serve as substrate for
the enzyme. Subsequently, we chemically synthesized the
SNAC monothioester of tricarballylic acid as substrate
mimic. Since HFB3 was the major metabolite accumulated
in theFUM14mutant, we first tested the activity of Fum14p
using HFB3 as the acceptor substrate and TCA-SNAC as
the acyl donor. HPLC analysis of the reaction mixture
showed the presence of a major peak at 16.93 min (Peak-1
in Figure 6C), which comigrated with standard HFB3,
and a smaller peak at 16.99 min (Peak-2 in Figure 6C),
which comigrated with standard FB3. Peak-2 was not
observed in the control where Fum14p was omitted in the
reaction (Figure 6B). To confirm the formation of FB3 in
the reaction, the reaction mixture was subjected to ESIMS
analysis. A clear molecular ion of 706.7m/z, which was
identical to standard FB3, was detected, in addition to the
390.6m/z ion for standard HFB3. Only the 390.6m/z ion,
but not the 706.7m/z ion, was present in the corresponding
fraction collected from the control reaction. We also tested
the activity of Fum14p using HFB4 as the acceptor and
TCA-SNAC as the donor. HPLC analysis of the reaction
mixture showed a single peak at 18.10 min, which comi-
grated with standard HFB4 (data not shown). Because FB4
and HFB4 have the same retention time under the experi-
mental conditions, we analyzed the reaction mixture by
ESIMS. The results showed that a 690.8m/z ion, which was
identical to standard FB4, was present in the fraction from
the reaction, but not from the control in which Fum14p was
not included. The control contained only the 374.6m/z ion
for HFB4. The results show that Fum14p is able to esterify
HFB3 and HFB4 using TCA-SNAC as the acyl donor to
produce the corresponding fumonisins. Finally, we tested the
activity of the C domain (Fum14p-C) using HFB3 or HFB4
as the acceptor. The results from HPLC and ESIMS analysis
suggest that no fumonisin was formed in the reactions (data
not shown).
Esterification of HFB1 by Fum14p and Fum14p-C. To
obtain information about the specificity of Fum14p toward
the acceptor substrate, we further tested the esterification of
FIGURE 4: HPLC-ELSD analysis of metabolites produced inF.
Verticillioide. (A) wild-type; (B) FUM14 deletion mutant. The
identity of the peaks on the wild-type panel is indicated.
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HFB1, which is the hydrolyzed form of FB1 but that was
not detected in extracts ofFUM14 deletion mutants (see
Figure 4). HFB1 contains one more hydroxyl (C-5 hydroxyl)
than HFB3 and two more hydroxyl (C-5 and C-10 hydroxyl)
than HFB4. Reactions that included HFB1, the thio-
ester TCA-SNAC, and the intact enzyme Fum14p yielded
two peaks upon HPLC analysis, one peak at 15.0 min
(Peak-1) and the other at 15.6 min (Peak-2) (Figure 7B).
Peak-1 comigrated with standard HFB1 (Figure 7A), but
Peak-2 did not comigrate with standard FB1, which had a
retention time of 16.1 min (Figure 7C). ESIMS analysis
revealed that the reaction mixture contained a new product
with a [M + H]+ ion of 564.2m/z, in addition to HFB1,
which has a [M+ H]+ ion of 406.5m/z. The product with
a [M + H]+ ion of 564.2m/z is coincident with PHFB1, the
partly hydrolyzed FB1 that contains only one of the two
tricarballylic esters of FB1 (25). It is not clear at this time
which regioisomer (C-14 ester or C-15 ester) of PHFB1 might
be formed in the reaction. When the C domain (Fum14p-C)
was used in the reaction instead of the intact protein, two
peaks were also detected on HPLC (Figure 8B). The first
peak (Peak-2) comigrated with PHFB1, whereas the second
peak (Peak-3) comigrated with FB1 (Figure 8C). The identity
of the two peaks was confirmed by ESIMS. The [M+ H]+
for Peak-2 was 564.6m/z, which is identical to that for
PHFB1, and the [M+ H]+ for Peak-3 was 722.7m/z, which
is identical to that for FB1. The results show that both the
Fum14p and Fum14p-C proteins were able to esterify HFB1
in vitro.
FIGURE 5: Sodium dodecyl sulfate-polyacrylamide gel analysis of Fum14p expressed inE. coli. (A) The condensation domain of Fum14p.
lane 1, total soluble proteins; lane 2, purified protein; lane 3, protein size markers. (B) Intact Fum14p. Lane 1, protein size markers; lane
2, purified protein; lane 3, total soluble proteins. The conserved motif for the condensation domain and peptidyl carrier protein of nonribosomal
peptides is listed under the SDS-PAGE. HTS1, HC-toxin synthetase (Q01886) fromCochliobolus carbonum; HMWP2, high-molecular-
weight protein 2 (P48633) fromYersinia enterocolitica; EntF, enterobactin synthetase component F (P11454) fromE. coli.
FIGURE 6: HPLC-ELSD analysis of the reaction catalyzed by
Fum14p using HFB3 as substrate in the presence of TCA thioester.
(A) Standard FB1, FB2, and FB3; (B) standard HFB3; (C) reaction
mixture.
FIGURE 7: HPLC-ELSD analysis of the reaction catalyzed by
Fum14p using HFB1 as substrate in the presence of TCA thioester.
(A) Standard HFB1; (B) reaction mixture; (C) standard FB1.
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DISCUSSION
Typical NRPS are modular enzymes, with each module
(except initiation module and termination module) minimally
containing three domains, the adenylation domain, PCP, and
the condensation domain (13, 16). The enzymes are multi-
functional complexes consisting of several modules in a
single polypeptide. For example, the NRPS cyclosporine A
synthetase includes 11 modules (26). FUM14 is predicted
to encode an NRPS with only the PCP and C domains. To
define the role ofFUM14 in fumonisin biosynthesis, we
generatedFUM14 deletion mutants ofF. Verticillioides, in
which the protein coding region ofFUM14 was replaced
with a hygromycin resistance gene. This approach was used
previously to define the function of otherFUM genes (20,
27, 28). HPLC and ESIMS analysis of extracts of theFUM14
deletion mutants revealed that the mutants did not produce
any of the typical B-series fumonisins FB1, FB2, FB3, and
FB4. Instead, the mutants produced pre-fumonisins, HFB3
and HFB4, which are identical to FB3 and FB4, respectively,
except that they lack the TCA ester functions. The fact that
the mutants lost the ability to produce the TCA-esterified
fumonisins indicates thatFUM14 is involved in the esteri-
fication of fumonisins. The results are consistent with the
preliminary observations determined previously (12). The
absence of partly esterified products (PHFB) in the mutant
extracts suggests thatFUM14 is responsible for the TCA
esters at both C-14 and C-15 of the fumonisin backbone.
PCP and C domains of NRPS have not been reported
previously to catalyze the formation of the C-O bone of
ester functions. Thus, the PCP and C domains of Fum14p
could be unusual in their activity. To further characterize
this unusual activity, we conducted a heterologous expression
analysis of Fum14p. This analysis has been challenging due
to the difficulty in the heterologous expression of the genes
from F. Verticillioides (29, 30). We were able to express
FUM14 in E. coli and purify the protein to near homogeneity
only after it was fused to maltose binding protein (MBP).
The in vitro assays showed that the intact enzyme was able
to convert HFB3 to FB3 and HFB4 to FB4, using TCA
thioester as the acyl donor. The results have two important
implications. First, the biochemical data provide direct
evidence for the function of Fum14p, that is, that it catalyzes
the esterification of TCAs to both C-14 and C-15 of the
fumonisin backbone. The biochemical data are also consistent
with the results from theFUM14 deletion analysis.FUM14
represents the third gene among the 15-gene cluster for
FIGURE 8: HPLC-ELSD analysis of the reaction catalyzed by the
condensation domain of Fum14p using HFB1 as substrate in the
presence of TCA thioester. (A) Standard HFB1; (B) reaction
mixture; (C) standard FB1.
FIGURE 9: A proposed mechanism for the NRPS-catalzyed tricarballylic ester formation of fumonisins. Note that an unsaturated tricarboxylate,
such as aconitic acid, is proposed to be the origin of the tricarballylic esters in vivo. ThreeFUM genes,FUM10, FUM14, andFUM7,
together code for a four-domain NRPS complex to catalyze the adenylation, thiolation, condensation, and reduction of the tricarballylic
esters of fumonisins.
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biosynthesis of fumonisins that has been biochemically
characterized (29, 30). Because of the importance of the
esters in the fumonisin toxicity, it is significant to define
the genetic and biochemical basis of their formation. Second,
the in vitro data demonstrate the first example of NRPS-
catalyzed C-O bond formation. Fum14p contains PCP and
C domain, in which the C domain is the catalytic unit
according to the paradigm of NRPS-catalyzed reactions (13,
16). In typical NRPS, the C domain catalyzes the condensa-
tion reaction of a peptidyl-S-PCP and an aminoacyl-S-PCP
to produce a new amide bond (13, 16). The substrates are
covalently linked to the enzyme via the 4′-phosphopanteth-
einyl group of the PCP domain. Acyl-SNAC is a mimic of
acyl-S-PCP, which is commonly used as substrate in the in
vitro studies of NRPS and polyketide synthases (31, 32). In
its natural environment, Fum14p is predicted to catalyze a
condensation reaction between an enzyme-bound substrate
(TCA-SNAC mimic) and a free substrate (hydrolyzed FB)
to form an ester bond. It is noteworthy that the C domain
alone (Fum14p-C) appeared inactive when HFB3 or HFB4
was used as the substrate, but active when HFB1 was the
substrate. The reason for the difference is not clear but could
be related to the C-5 hydroxyl group on HFB1 that may
provide a favorable interaction with the enzyme. The fact
that HFB1 was converted to PHFB1 and FB1 by Fum14p-C
shows that the removal of the PCP domain did not lead to
an inactive enzyme.
Three genes,FUM7, FUM10, and FUM14, have been
suggested to be involved in the esterification of fumonisins
(12). The genes together may encode an NRPS complex.
FUM10 is similar to genes coding for the adenylation
domains of NRPS, whereasFUM14 encodes the PCP and
condensation domain of NRPS.FUM7 is similar to genes
for dehydrogenases/reductases, which could be regarded as
a reductase (R) domain of NRPS. Together, the genes could
encode a four-domain NRPS complex, A-PCP-C-R. On
the basis of the data obtained from this study and previous
studies (11, 12), we propose a mechanism for the biosynthesis
of the TCA esters of fumonisins (Figure 9). The first step is
the ATP-dependent activation of a tricarboxylate substrate
by Fum10p to form an acyl-AMP, which is subsequently
transferred to the PCP domain of Fum14p. The exact
substrate for Fum10p is not known yet, but was suggested
to be an intermediate of the Krebs Cycle (10). Preliminary
data obtained from the disrupted mutants ofFUM10 and
FUM7 suggested that the substrate of Fum10p could be a
tricarboxylate containing a double bond (12), such as aconitic
acid (Figure 9). The second step is the C domain-catalyzed
condensation between acyl-S-PCP of Fum14p and HFB3 or
HFB4 to produce a didehydro-intermediate of FB3 or FB4,
respectively. If this is the case, the direct substrate in vivo
for the C domain could be an unsaturated tricarboxylate
thioester, rather than the TCA thioester that we used in our
enzyme assays in vitro. Attempts to chemically synthesize
a monothioester of aconitic acid as an unsaturated analog of
TCA-SNAC have been frustrated by the difficulties of
dealing with the reactive functionality in the molecule (Xu,
C. and Dussault, P. H., unpublished results). The last step is
the reduction of the double bond in the didehydro-intermedi-
ate by Fum7p to produce FB3 and FB4 (Figure 9). A
hydroxylation at carbon-5 will convert FB3 and FB4 to FB1
and FB2, respectively. This step is believed to be the last
step in the whole biosynthetic pathway and has been
characterized (27, 29). We are currently working on the
characterization of Fum10p and Fum7p to provide further
evidence for the proposed mechanism for esterification of
fumonisins.
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SUPPORTING INFORMATION AVAILABLE
Procedures for the synthesis of tricarballylic acid mono-
thioesters,N-acetylcysteamine (1) and phenyl (2) mono-
thioesters of tricarballylic acid. This material is available free
of charge via the Internet at http://pubs.acs.org.
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